This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Glaucoma Research Society | |
|---|---|
| Name | Glaucoma Research Society |
| Type | Nonprofit |
| Founded | 1980 |
| Location | International |
| Focus | Ophthalmology, visual sciences, clinical research |
Glaucoma Research Society is an international nonprofit organization dedicated to research, education, and advocacy in the field of glaucoma and optic neuropathies. It supports basic science, translational research, and clinical trials while convening clinicians, scientists, and policy makers from major institutions and associations worldwide. The Society engages with academic centers, professional societies, and funding agencies to accelerate therapies, diagnostics, and public awareness for vision preservation.
The Society was established in 1980 amid growing interest in glaucoma following discoveries at institutions such as Johns Hopkins Hospital, Massachusetts Eye and Ear, Moorfields Eye Hospital, Bascom Palmer Eye Institute, and Wills Eye Hospital. Early contributors included investigators affiliated with Harvard Medical School, Stanford University School of Medicine, University College London, University of California, San Francisco, and University of Pennsylvania Perelman School of Medicine. The organization expanded through partnerships with societies like American Academy of Ophthalmology, European Society of Ophthalmology, World Ophthalmology Congress, and Association for Research in Vision and Ophthalmology. Collaborations with funding bodies such as the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, Medical Research Council (United Kingdom), and European Research Council helped launch multicenter studies, while ties to philanthropic foundations including Bill & Melinda Gates Foundation, Lions Clubs International Foundation, and Howard G. Buffett Foundation supported global screening initiatives.
The Society’s mission aligns with the priorities of organizations like World Health Organization, United Nations, and Pan American Health Organization to reduce avoidable blindness. Objectives emphasize translational pipelines that connect discoveries from laboratories at Broad Institute, Salk Institute, Cold Spring Harbor Laboratory, Max Planck Institute, and Karolinska Institutet to clinical trials at centers such as Mayo Clinic, Cleveland Clinic, Singapore National Eye Centre, and Aravind Eye Care System. Core goals mirror strategies used by National Eye Institute, European Glaucoma Society, and Royal College of Ophthalmologists: improve diagnostics, develop neuroprotective therapies, and enhance access to care in low-resource settings served by Médecins Sans Frontières and Orbis International.
Research programs span basic science, biomarker discovery, imaging, genetics, and therapeutics. Projects have built on genetic findings from teams at Broad Institute, Wellcome Sanger Institute, Imperial College London, Johns Hopkins University School of Medicine, and Vanderbilt University Medical Center to investigate loci associated with intraocular pressure and optic nerve vulnerability. Imaging initiatives involve collaborators from Massachusetts Institute of Technology, Duke University School of Medicine, University of Oxford, Technical University of Munich, and Kyoto University to refine optical coherence tomography and adaptive optics. Clinical trials have been coordinated with networks like ClinicalTrials.gov registries linked to Food and Drug Administration, European Medicines Agency, National Health Service (England), and regulatory bodies in Australia and Canada. Programs addressing health disparities reference work by Centers for Disease Control and Prevention, Kaiser Permanente, Johns Hopkins Bloomberg School of Public Health, and Bill & Melinda Gates Foundation partners.
The Society organizes symposia, workshops, and annual meetings featuring speakers from institutions such as Columbia University Irving Medical Center, Yale School of Medicine, University of Toronto Faculty of Medicine, University of Sydney, and Seoul National University College of Medicine. It co-sponsors sessions at major gatherings like American Society of Retina Specialists Annual Meeting, European Society of Cataract and Refractive Surgeons Congress, World Glaucoma Congress, Association for Research in Vision and Ophthalmology Annual Meeting, and regional conferences hosted by Indian National Science Academy and Chinese Academy of Sciences. Special events often include panels with representatives from National Eye Institute, Wellcome Trust, Alcon Foundation, AbbVie, and academic consortia such as NEI Audacious Goals Initiative.
The Society disseminates findings through journals and resources in partnership with publishers and editorial boards at outlets like Investigative Ophthalmology & Visual Science, Ophthalmology, British Journal of Ophthalmology, JAMA Ophthalmology, and Nature Medicine. It issues clinical guidelines aligned with recommendations from European Glaucoma Society, American Glaucoma Society, Royal College of Ophthalmologists, Canadian Ophthalmological Society, and Royal Australian and New Zealand College of Ophthalmologists. Educational materials reference consensus statements from World Health Organization, review articles from The Lancet, and methodological standards used by CONSORT and STROBE groups. The Society curates databases and repositories in collaboration with GenBank, dbGaP, European Genome-phenome Archive, and major academic libraries.
Governance follows nonprofit models used by entities such as American Cancer Society, Alzheimer's Association, American Heart Association, and The Rockefeller Foundation, with a board drawn from clinicians and scientists at Harvard Medical School, Stanford University, University College London, University of Tokyo, and Karolinska Institutet. Funding sources include competitive grants from National Institutes of Health, cooperative agreements with European Commission Horizon 2020, philanthropic gifts from families and foundations like Gates Foundation and corporate partnerships with companies such as Novartis, Allergan, Bausch + Lomb, GlaxoSmithKline, and Roche. Financial oversight aligns with standards applied by Internal Revenue Service nonprofit regulations and auditing practices used by Big Four accounting firms.
The Society partners with academic centers, professional societies, industry, and global health organizations, including Aravind Eye Care System, Seva Foundation, Orbis International, International Agency for the Prevention of Blindness, World Health Organization, American Academy of Ophthalmology, European Society of Ophthalmology, Association for Research in Vision and Ophthalmology, Alcon, Novartis, Allergan, Bausch + Lomb, Pfizer, Roche, Genentech, GlaxoSmithKline, and research consortia at Broad Institute, Wellcome Trust Sanger Institute, Max Planck Institute for Biological Cybernetics, National Eye Institute, and European Research Council. Collaborative projects have linked investigators from Moorfields Eye Hospital, Bascom Palmer Eye Institute, Wills Eye Hospital, Massachusetts Eye and Ear, Johns Hopkins Hospital, Mayo Clinic, Cleveland Clinic, Singapore National Eye Centre, Aravind Eye Care System, University of Cape Town, and University of São Paulo to address global burden, policy, and translational pipelines.
Category:Medical research organizations